Bisulfite patch PCR enables multiplexed sequencing of promoter methylation across cancer samples

Genome Research

Volumn 20, Issue 9, 2010, Pages 1279-1287

  Varley, Katherine Elena ^a   Mitra, Robi David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BREAST CANCER; COLON CANCER; DNA METHYLATION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

COLONIC NEOPLASMS; DNA; DNA METHYLATION; GENOME, HUMAN; HUMANS; NEOPLASMS; NUCLEAR PORE COMPLEX PROTEINS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SULFITES;

EID: 77956296566     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.101212.109     Document Type: Article

References (34)

1. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH, Xie B, Daley GQ, Church GM. 2009. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 27: 361-368.
2. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. 1998. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196.
3. The Cancer Genome Atlas Research Network. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
4. Chan TA, Glockner S, Yi JM, Chen W, Van Neste L, Cope L, Herman JG, Velculescu V, Schuebel KE, Ahuja N, et al. 2008. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med 5: e114. doi: 10.1371/journal.pmed.0050114.
5. Cokus SJ, Feng S, Zhang X, Chen Z, Merriman B, Haudenschild CD, Pradhan S, Nelson SF, Pellegrini M, Jacobsen SE. 2008. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 452: 215-219. (Pubitemid 351380251)
6. Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J, Egli D, Maherali N, Park IH, Yu J, et al. 2009. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 27: 353-360.
7. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. 2000. MethyLight: A high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: e32. http://nar.oxfordjournals.org/cgi/ content/abstract/28/8/e32.
8. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D. 2005. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci 102: 15785-15790. (Pubitemid 41552820)
9. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. 2000. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl JMed 343: 1350-1354.
10. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci 89: 1827-1831.
11. Hodges E, Xuan Z, Balija V, Kramer M, Molla MN, Smith SW, Middle CM, Rodesch MJ, Albert TJ, Hannon GJ, et al. 2007. Genome-wide in situ exon capture for selective resequencing. Nat Genet 39: 1522-1527. (Pubitemid 350191350)
12. Hodges E, Smith A, Kendall J, Xuan Z, Ravi K, Rooks M, Zhang M, Ye K, Battacharjee A, Brizuela L et al. 2009. High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Research 19: 1593-1605
13. Jun HJ, Woolfenden S, Coven S, Lane K, Bronson R, Housman D, Charest A. 2009. Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas. Cancer Res 69: 2180-2184.
14. Kim JY, Tavare S, Shibata D. 2006. Human hair genealogies and stem cell latency. BMC Biol 4: 2. doi: 10.1186/1741-7007-4-2.
15. Klarmann GJ, Decker A, Farrar WL. 2008. Epigenetic gene silencing in the Wnt pathway in breast cancer. Epigenetics 3: 59-63.
16. Korshunova Y, Maloney RK, Lakey N, Citek RW, Bacher B, Budiman A, Ordway JM, McCombie WR, Leon J, Jeddeloh JA, et al. 2008. Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res 18: 19-29.
17. Laird PW. 2005. Cancer epigenetics. Hum Mol Genet 14: R65-R76.
18. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, et al. 2007. Clustal W and Clustal X version 2. Bioinformatics 23: 2947-2948.
19. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. 2009. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315-322.
20. Lyko F, Brown R. 2005. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 97: 1498-1506. (Pubitemid 41631949)
21. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, et al. 2008. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-770.
22. Munson K, Clark J, Lamparska-Kupsik K, Smith SS. 2007. Recovery of bisulfite-converted genomic sequences in the methylation-sensitive QPCR. Nucleic Acids Res 35: 2893-2903. (Pubitemid 47073628)
23. Nabilsi NH, Broaddus RR, Loose DS. 2009. DNA methylation inhibits p53-mediated survivin repression. Oncogene 28: 2046-2050.
24. Porreca GJ, Zhang K, Li JB, Xie B, Austin D, Vassallo SL, LeProust EM, Peck BJ, Emig CJ, Dahl F, et al. 2007. Multiplex amplification of large sets of human exons. Nat Methods 4: 931-936. (Pubitemid 350042382)
25. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N et al. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274. (Pubitemid 44571966)
26. Suzuki H, Toyota M, Carraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, et al. 2008. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 98: 1147-1156. (Pubitemid 351399804)
27. Taylor KH, Kramer RS, Davis JW, Guo J, Duff DJ, Xu D, Caldwell CW, Shi H. 2007. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 67: 8511-8518. (Pubitemid 47437425)
28. Tomii K, Tsukuda K, Toyooka S, Dote H, Hanafusa T, Asano H, Naitou M, Doihara H, Kisimoto T, Katayama H, et al. 2007. Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. Int J Cancer 120: 566-573. (Pubitemid 44969028)
29. Ushijima T. 2005. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5: 223-231. (Pubitemid 40314953)
30. Varley KE, Mitra RD. 2008. Nested Patch PCR enables highly multiplexed mutation discovery in candidate genes. Genome Res 18: 1844-1850.
31. Varley KE, Mutch DG, Edmonston TB, Goodfellow PJ, Mitra RD. 2009. Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing. Nucleic Acids Res 37: 4603-4612
32. Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD, et al. 1998. Biallelic inactivation of hMLH1 by epigenetic gene silencing: A novel mechanism causing human MSI cancers. Proc Natl Acad Sci 95: 8698-8702. (Pubitemid 28350551)
33. Widschwendter M, Siegmund KD, Muller HM, Fiegl H, Marth C, Muller-Holzner E, Jones PA, Laird PW. 2004. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 64: 3807-3813. (Pubitemid 38697289)
34. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113. (Pubitemid 350134889)